Transgenomic's Q2 Revenues Dip 7 Percent

The firm said that its instrument business was negatively impacted by lower consumables revenues, product mix, and currency translation.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories